https://www.selleckchem.com/pr....oducts/buloxibutid.h
Objectives The purpose of this study was to demonstrate the clinical feasibility of an integrated reference phantom method for quantitative ultrasound by creating an ultrasound-derived fat fraction (UDFF) tool. This tool was evaluated with respect to its diagnostic performance as a biomarker for assessing histologic hepatic steatosis and its agreement with the magnetic resonance imaging (MRI) proton density fat fraction (PDFF). Methods Adults (n = 101) with known or suspected nonalcoholic fatty liver disease consented to participate
Aimer
Commentaire
Partagez
